SETD7 Controls Intestinal Regeneration and Tumorigenesis by Regulating Wnt/β-Catenin and Hippo/YAP Signaling

Developmental Cell

Volumn 37, Issue 1, 2016, Pages 47-57

  Oudhoff, Menno J ^a,g   Braam, Mitchell J S ^a   Freeman, Spencer A ^a   Wong, Denise ^a   Rattray, David G ^a   Wang, Jia ^a   Antignano, Frann ^a   Snyder, Kimberly ^a   Refaeli, Ido ^a   Hughes, Michael R ^a   McNagny, Kelly M ^a   Gold, Michael R ^a   Arrowsmith, Cheryl H ^b,c   Sato, Toshiro ^d   Rossi, Fabio M V ^a   Tatlock, John H ^e   Owen, Dafydd R ^e   Brown, Peter J ^b   Zaph, Colby ^a,f  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d KEIO UNIVERSITY   (Japan)

^e PFIZER INC   (United States)

^f MONASH UNIVERSITY   (Australia)

^g NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; HIPPO ASSOCIATED PROTEIN; HISTONE LYSINE METHYLTRANSFERASE; PROTEIN; SETD7 PROTEIN; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN; AXIN; AXIN1 PROTEIN, MOUSE; PHOSPHOPROTEIN; PROTEIN METHYLTRANSFERASE; SETD7 PROTEIN, MOUSE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA; WNT PROTEIN; YAP PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACO 2 CELL LINE; CARCINOGENESIS; CELL PROLIFERATION; CELL REGENERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENTERITIS; GENE EXPRESSION; HEK293 CELL LINE; HISTONE METHYLATION; HUMAN; HUMAN CELL; INTESTINAL REGENERATION; INTESTINE; INTESTINE EPITHELIUM; INTESTINE TUMOR; LARGE INTESTINE; MCF 7 CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SMALL INTESTINE; UPREGULATION; WHOLE BODY RADIATION; WNT SIGNALING PATHWAY; ANIMAL; C57BL MOUSE; CELL TRANSFORMATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; METHYLATION; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AXIN PROTEIN; BETA CATENIN; CACO-2 CELLS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; HEK293 CELLS; HUMANS; INTESTINAL NEOPLASMS; INTESTINES; MCF-7 CELLS; METHYLATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOPROTEINS; PROTEIN METHYLTRANSFERASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84963704107     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2016.03.002     Document Type: Article

References (66)

1. Ashton G.H., Morton J.P., Myant K., Phesse T.J., Ridgway R.A., Marsh V., Wilkins J.A., Athineos D., Muncan V., Kemp R., et al. Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling. Dev. Cell 2010, 19:259-269.
2. Azzolin L., Zanconato F., Bresolin S., Forcato M., Basso G., Bicciato S., Cordenonsi M., Piccolo S. Role of TAZ as mediator of Wnt signaling. Cell 2012, 151:1443-1456.
3. Azzolin L., Panciera T., Soligo S., Enzo E., Bicciato S., Dupont S., Bresolin S., Frasson C., Basso G., Guzzardo V., et al. YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response. Cell 2014, 158:157-170.
4. Barker N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat. Rev. Mol. Cell Biol. 2014, 15:19-33.
5. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
6. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., Danenberg E., Clarke A.R., Sansom O.J., Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
7. Barry E.R., Morikawa T., Butler B.L., Shrestha K., de la Rosa R., Yan K.S., Fuchs C.S., Magness S.T., Smits R., Ogino S., et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 2013, 493:106-110.
8. Barsyte-Lovejoy D., Li F., Oudhoff M.J., Tatlock J.H., Dong A., Zeng H., Wu H., Freeman S.A., Schapira M., Senisterra G.A., et al. (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells. Proc. Natl. Acad. Sci. USA 2014, 111:12853-12858.
9. Buczacki S.J.A., Zecchini H.I., Nicholson A.M., Russell R., Vermeulen L., Kemp R., Winton D.J. Intestinal label-retaining cells are secretory precursors expressing Lgr5. Nature 2013, 495:65-69.
10. Byun M.R., Hwang J.-H., Kim A.R., Kim K.M., Hwang E.S., Yaffe M.B., Hong J.-H. Canonical Wnt signalling activates TAZ through PP1A during osteogenic differentiation. Cell Death Differ. 2014, 21:854-863.
11. Cai J., Zhang N., Zheng Y., de Wilde R.F., Maitra A., Pan D. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 2010, 24:2383-2388.
12. Cai J., Maitra A., Anders R.A., Taketo M.M., Pan D. β-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis. Genes Dev. 2015, 29:1493-1506.
13. Camargo F.D., Gokhale S., Johnnidis J.B., Fu D., Bell G.W., Jaenisch R., Brummelkamp T.R. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 2007, 17:2054-2060.
14. Clevers H., Nusse R. Wnt/β-catenin signaling and disease. Cell 2012, 149:1192-1205.
15. Cong F., Varmus H. Nuclear-cytoplasmic shuttling of Axin regulates subcellular localization of -catenin. Proc. Natl. Acad. Sci. USA 2004, 101:2882-2887.
16. Dupont S., Morsut L., Aragona M., Enzo E., Giulitti S., Cordenonsi M., Zanconato F., Le Digabel J., Forcato M., Bicciato S., et al. Role of YAP/TAZ in mechanotransduction. Nature 2011, 474:179-183.
17. Fang L., Zhang L., Wei W., Jin X., Wang P., Tong Y., Li J., Du J.X., Wong J. A methylation-phosphorylation switch determines Sox2 stability and function in ESC maintenance or differentiation. Mol. Cell 2014, 55:537-551.
18. Gregorieff A., Liu Y., Inanlou M.R., Khomchuk Y., Wrana J.L. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer. Nature 2015, 526:715-718.
19. Harvey K.F., Zhang X., Thomas D.M. The Hippo pathway and human cancer. Nat. Rev. Cancer 2013, 13:246-257.
20. Hata S., Hirayama J., Kajiho H., Nakagawa K., Hata Y., Katada T., Furutani-Seiki M., Nishina H. A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents. J. Biol. Chem. 2012, 287:22089-22098.
21. Heallen T., Zhang M., Wang J., Bonilla-Claudio M., Klysik E., Johnson R.L., Martin J.F. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011, 332:458-461.
22. Henderson B.R. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat. Cell Biol. 2000, 2:653-660.
23. Herz H.-M., Garruss A., Shilatifard A. SET for life: biochemical activities and biological functions of SET domain-containing proteins. Trends Biochem. Sci. 2013, 38:621-639.
24. Huber A.H., Weis W.I. The structure of the β-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by β-catenin. Cell 2001, 105:391-402.
25. Imajo M., Miyatake K., Iimura A., Miyamoto A., Nishida E. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β-catenin signalling. EMBO J. 2012, 31:1109-1122.
26. Imajo M., Ebisuya M., Nishida E. Dual role of YAP and TAZ in renewal of the intestinal epithelium. Nat. Cell Biol. 2014, 17:7-19.
27. Kim N.G., Koh E., Chen X., Gumbiner B.M. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc. Natl. Acad. Sci. USA 2011, 108:11930-11935.
28. Kim E., Kim M., Woo D.-H., Shin Y., Shin J., Chang N., Oh Y.T., Kim H., Rheey J., Nakano I., et al. Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell 2013, 23:839-852.
29. Lehnertz B., Rogalski J.C., Schulze F.M., Yi L., Lin S., Kast J., Rossi F.M. p53-dependent transcription and tumor suppression are not affected in Set7/9-deficient mice. Mol. Cell 2011, 43:673-680.
30. Li W., Cooper J., Zhou L., Yang C., Erdjument-Bromage H., Zagzag D., Snuderl M., Ladanyi M., Hanemann C.O., Zhou P., et al. Merlin/NF2 loss-driven tumorigenesis linked to CRL4DCAF1-mediated inhibition of the hippo pathway Kinases Lats1 and 2 in the nucleus. Cancer Cell 2014, 26:48-60.
31. Lu L., Gao Y., Zhang Z., Cao Q., Zhang X., Zou J., Cao Y. Kdm2a/b lysine demethylases regulate canonical Wnt signaling by modulating the stability of nuclear β-catenin. Dev. Cell 2015, 33:660-674.
32. Mazur P.K., Reynoird N., Khatri P., Jansen P.W.T.C., Wilkinson A.W., Liu S., Barbash O., Van Aller G.S., Huddleston M., Dhanak D., et al. SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer. Nature 2014, 510:283-287.
33. Merritt A.J., Potten C.S., Kemp C.J., Hickman J.A., Balmain A., Lane D.P., Hall P.A. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 1994, 54:614-617.
34. Metcalfe C., Kljavin N.M., Ybarra R., de Sauvage F.J. Lgr5+ stem cells are indispensable for radiation-induced intestinal regeneration. Cell Stem Cell 2014, 14:149-159.
35. Montgomery R.K., Carlone D.L., Richmond C.A., Farilla L., Kranendonk M.E.G., Henderson D.E., Baffour-Awuah N.Y., Ambruzs D.M., Fogli L.K., Algra S., Breault D.T. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc. Natl. Acad. Sci. USA 2011, 108:179-184.
36. Muñoz J., Stange D.E., Schepers A.G., van de Wetering M., Koo B.-K., Itzkovitz S., Volckmann R., Kung K.S., Koster J., Radulescu S., et al. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent "+4" cell markers. EMBO J. 2012, 31:3079-3091.
37. Muzny D.M., Bainbridge M.N., Chang K., Dinh H.H., Drummond J.A., Fowler G., Kovar C.L., Lewis L.R., Morgan M.B., Newsham I.F., et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337.
38. Oudhoff M.J., Freeman S.A., Couzens A.L., Antignano F., Kuznetsova E., Min P.H., Northrop J.P., Lehnertz B., Barsyte-Lovejoy D., Vedadi M., et al. Control of the hippo pathway by Set7-dependent methylation of Yap. Dev. Cell 2013, 26:188-194.
39. Park H.W., Kim Y.C., Yu B., Moroishi T., Mo J.-S., Plouffe S.W., Meng Z., Lin K.C., Yu F.-X., Alexander C.M., et al. Alternative Wnt signaling activates YAP/TAZ. Cell 2015, 162:780-794.
40. Pokutta S., Weis W.I. Structure of the dimerization and beta-catenin-binding region of alpha-catenin. Mol. Cell 2000, 5:533-543.
41. Powell A.E., Wang Y., Li Y., Poulin E.J., Means A.L., Washington M.K., Higginbotham J.N., Juchheim A., Prasad N., Levy S.E., et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 2012, 149:146-158.
42. Rosenbluh J., Nijhawan D., Cox A.G., Li X., Neal J.T., Schafer E.J., Zack T.I., Wang X., Tsherniak A., Schinzel A.C., Shao D.D., et al. β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 2012, 151:1457-1473.
43. Sangiorgi E., Capecchi M.R. Bmi1 is expressed in vivo in intestinal stem cells. Nat. Genet. 2008, 40:915-920.
44. Sansom O.J., Meniel V.S., Muncan V., Phesse T.J., Wilkins J.A., Reed K.R., Vass J.K., Athineos D., Clevers H., Clarke A.R. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007, 446:676-679.
45. Sato T., Clevers H. Primary mouse small intestinal epithelial cell cultures. Methods Mol. Biol. 2013, 945:319-328.
46. Sato T., Vries R.G., Snippert H.J., van de Wetering M., Barker N., Stange D.E., van Es J.H., Abo A., Kujala P., Peters P.J., Clevers H. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009, 459:262-265.
47. Schlegelmilch K., Mohseni M., Kirak O., Pruszak J., Rodriguez J.R., Zhou D., Kreger B.T., Vasioukhin V., Avruch J., Brummelkamp T.R., Camargo F.D. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 2011, 144:782-795.
48. Schmitz Y., Rateitschak K., Wolkenhauer O. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling. Cell Signal. 2013, 25:2210-2221.
49. Schwitalla S., Fingerle A.A., Cammareri P., Nebelsiek T., Göktuna S.I., Ziegler P.K., Canli O., Heijmans J., Huels D.J., Moreaux G., et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 2013, 152:25-38.
50. Shen C., Wang D., Liu X., Gu B., Du Y., Wei F.-Z., Cao L.-L., Song B., Lu X., Yang Q., et al. SET7/9 regulates cancer cell proliferation by influencing β-catenin stability. FASEB J. 2015, 29:4313-4323.
51. Silvis M.R., Kreger B.T., Lien W.-H., Klezovitch O., Rudakova G.M., Camargo F.D., Lantz D.M., Seykora J.T., Vasioukhin V. α-Catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci. Signal. 2011, 4:ra33.
52. Stewart B.W., Wild C.P. World Cancer Report 2014 2014, World Health Organization.
53. Takeda N., Jain R., LeBoeuf M.R., Wang Q., Lu M.M., Epstein J.A. Interconversion between intestinal stem cell populations in distinct niches. Science 2011, 334:1420-1424.
54. Tanaka T., Kohno H., Suzuki R., Hata K., Sugie S., Niho N., Sakano K., Takahashi M., Wakabayashi K. Dextran sodium sulfate strongly promotes colorectal carcinogenesis in Apc(Min/+) mice: inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms. Int. J. Cancer 2006, 118:25-34.
55. Tetteh P.W., Farin H.F., Clevers H. Plasticity within stem cell hierarchies in mammalian epithelia. Trends Cell Biol. 2015, 25:100-108.
56. Tetteh P.W., Basak O., Farin H.F., Wiebrands K., Kretzschmar K., Begthel H., van den Born M., Korving J., de Sauvage F., van Es J.H., et al. Replacement of lost Lgr5-positive stem cells through plasticity of their enterocyte-lineage daughters. Cell Stem Cell 2016, 18:203-213.
57. Tian H., Biehs B., Warming S., Leong K.G., Rangell L., Klein O.D., de Sauvage F.J. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 2011, 478:255-259.
58. van der Flier L.G., van Gijn M.E., Hatzis P., Kujala P., Haegebarth A., Stange D.E., Begthel H., van den Born M., Guryev V., Oving I., et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 2009, 136:903-912.
59. van Es J.H., Sato T., van de Wetering M., Lyubimova A., Yee Nee A.N., Gregorieff A., Sasaki N., Zeinstra L., van den Born M., Korving J., et al. Dll1+ secretory progenitor cells revert to stem cells upon crypt damage. Nat. Cell Biol. 2012, 14:1099-1104.
60. Varelas X., Miller B.W., Sopko R., Song S., Gregorieff A., Fellouse F.A., Sakuma R., Pawson T., Hunziker W., McNeill H. The Hippo pathway regulates Wnt/beta-catenin signaling. Dev. Cell 2010, 18:579-591.
61. Vermeulen L., Snippert H.J. Stem cell dynamics in homeostasis and cancer of the intestine. Nat. Rev. Cancer 2014, 14:468-480.
62. Vogelstein B., Papadopoulos N., Velculescu V.E., Zhou S., Diaz L.A., Kinzler K.W. Cancer genome landscapes. Science 2013, 339:1546-1558.
63. Wada K.-I., Itoga K., Okano T., Yonemura S., Sasaki H. Hippo pathway regulation by cell morphology and stress fibers. Development 2011, 138:3907-3914.
64. Yan Y., Kolachala V., Dalmasso G., Nguyen H., Laroui H., Sitaraman S.V., Merlin D. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One 2009, 4:e6073.
65. Zeng L., Fagotto F., Zhang T., Hsu W., Vasicek T.J., Perry W.L., Lee J.J., Tilghman S.M., Gumbiner B.M., Costantini F. The mouse fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 1997, 90:181-192.
66. Zhou D., Zhang Y., Wu H., Barry E., Yin Y., Lawrence E., Dawson D., Willis J.E., Markowitz S.D., Camargo F.D., Avruch J. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc. Natl. Acad. Sci. USA 2011, 108:E1312-E1320.